chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 2.0
Sex: M
Vaccine: FLUX
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: child received Fluzone Quadrivalent doses two weeks apart, no AE; Initial and additional information received on 26-Sep-2019 and 30-Sep-2019 regarding an unsolicited valid non-serious case received from a physician.  This case involves a 2 years old male patient who received twice 0.5 ml INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED (lot number: UJ237AB, expiry date: 30-Jun-2020), two weeks apart, on 11 Sep 2019 and 25 Sep 2019 in left thigh.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was an actual medication error due to inappropriate schedule of vaccine administration.  At the time of reporting the patient had no adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.
Sex: U
Vaccine: FLUR4
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Flublok Quadrivalent was given to a patient under 18 years of age, no AE; Initial information received on 26-Sep-2019 and Additional information was received on 27-Sep-2019 regarding an unsolicited valid non-serious case received from a other health professional via sales representative.  This case involves patient (less than 18 year of age) who was vaccinated with vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a Dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE lot number not reported via unknown route in unknown administration site.  It was a case of actual medication error due to Inappropriate age at vaccine administration.  At the time of the report, no adverse event was reported.  Information on the batch number was requested.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error  List of documents held by the sender: none
Sex: F
Vaccine: DTAPIPVHIB
Symptoms: Incorrect product formulation administered, No adverse event, Product preparation issue
Clinical narrative: a patient they believe received the diluent only and did not receive the Hib portion of Pentacel, no adverse event; Initial information received on 26-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 4 months old female patient who received the diluent only and did not receive the hib portion of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 20-Aug-2019, the patient received a second dose of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE lot U6187AA/U6137AA Exp date: 06-Feb-2021, via unknown route in the right thigh.  It was a case of actual medication error case due to Inappropriate reconstitution technique.   lot details: Lot #--The administering LPN documented the lot given as U6187AA with expiry 06Feb2021. The practice knows that the lone lyophilized Hib portion of Pentacel found in the refrigerator was UJ060AA from carton UJ060AAA, expiry 04Oct2020. PQC provided the corresponding diluent as lot U6137AA. The nurse documented everything the same with the exception of the "8" which she stated perhaps was supposed to be a "3". She says this LPN is known to have such errors in documentation. This is the closest lot that the practice can find to the one provided by PQC as corresponding to the lone Hib and carton that was found.)  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.
Sex: F
Vaccine: FLU3
Symptoms: Exposure via skin contact, Injection site bruising, Underdose
Clinical narrative: bruise at injection site; consumer having a complete dose of Fluzone High-Dose due to after the injection having just a little bit of fluid to come back out; consumer having a complete dose of Fluzone High-Dose due to after the injection having just a little bit of fluid to come back out; Initial information received on 26-Sep-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a 70 years old female patient who experienced bruise at injection site (vaccination site bruising), consumer having a complete dose of fluzone high-dose due to after the injection having just a little bit of fluid to come back out (underdose and exposure via skin contact) while she received vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] and while treated with ACETYLSALICYLIC ACID [ASPRIN].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a  dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE lot UJ238AB via intramuscular route in the left arm.  On an unknown date, The patient developed a non-serious bruise at injection site (vaccination site bruising) (Unknown latency) following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE.  It was a case of actual medication error due to underdose and exposure via skin contact.   Final diagnosis was consumer having a complete dose of fluzone high-dose due to after the injection having just a little bit of fluid to come back out and bruise at injection site.  On an unknown date, the patient started taking ASPRIN (ACETYLSALICYLIC ACID) dosage unknown (with an unknown batch number). as corrective treatment  The patient outcome is reported as Unknown for bruise at injection site.
Sex: F
Vaccine: FLUR4
Symptoms: Erythema, Urticaria
Clinical narrative: reaction 5 mins after shot. large welt came up and it was red; reaction 5 mins after shot. large welt came up and it was red; Initial information received on 26-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case was linked to 2019SA271041 (same reporter).  This case involves a 30 years old female patient who experienced large welt came up (urticarial) and it was red (erythema), while she received vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   No concomitant medication received.  On 24-Sep-2019, the patient received a single dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE lot number not reported in the left deltoid.  On an unknown date, The patient developed a non-serious large welt came up and it was red (urticaria) (erythema) 5 minutes following the administration of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE.  No lab test reported. . Final diagnosis was reaction large welt came up and it was red.   It was not reported if the patient received a corrective treatment.  The patient outcome is reported as Unknown for the events.  Information on the batch number was requested.
Sex: F
Vaccine: FLUR4
Symptoms: Erythema, Urticaria
Clinical narrative: reaction 5 mins after shot. large welt came up and it was red; reaction 5 mins after shot. large welt came up and it was red; Initial information received on 26-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case was linked to 2019SA271040 (same reporter).  This case involves a 70 years old female patient who experienced large welt came up (urticarial) and it was red (erythema), while she received vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   No concomitant medication received.  On 24-Sep-2019, the patient received a single dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE lot number not reported in the left deltoid.  On an unknown date, The patient developed a non-serious large welt came up and it was red (urticaria) (erythema) 5 minutes following the administration of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE.  No lab test reported. . Final diagnosis was reaction large welt came up and it was red.   It was not reported if the patient received a corrective treatment.  The patient outcome is reported as Unknown for the events.  Information on the batch number was requested.
Sex: M
Vaccine: FLUR4
Symptoms: Injected limb mobility decreased, Pain in extremity, Pyrexia
Clinical narrative: unable to lift the left arm up (only about halfway); mild, constant pain in left arm/stung really bad; fever up 102F; Initial information received on 26-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case involves a 48 years old male patient who experienced fever up 102f (pyrexia), mild, constant pain (pain in extremity) in left arm/stung really bad and unable to lift the left arm up (only about halfway) (movement disorder), while he received vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV].  The patient's past medical history, concomitant therapy, medical treatment(s), vaccination(s) and family history were not provided.   On 24-Sep-2019, the patient received a 0.5 ml dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE lot number not reported via intramuscular route in the left deltoid.  On 24-Sep-2019, The patient developed a non-serious fever up 102f (pyrexia) few hours following the administration of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE.  On an unknown date, The patient developed a non-serious mild, constant pain in left arm/stung really bad (pain in extremity) and unable to lift the left arm up (only about halfway) (movement disorder) Unknown latency following the administration of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE.  Body temperature - On 24-Sep-2019: 38.8 Cel [38.8]  Final diagnosis was fever up 102f, unable to lift the left arm up (only about halfway) and mild, constant pain in left arm/stung really bad.   It was not reported if the patient received a corrective treatment.  The patient outcome is reported as Recovered / Resolved on an unknown date for fever up 102f, as Unknown for mild, constant pain in left arm/stung really bad and as Unknown for unable to lift the left arm up (only about halfway).  Information on the batch number was requested.
Sex: F
Vaccine: FLUX
Symptoms: Chills, Malaise, Pyrexia
Clinical narrative: fever; chills; sick; Initial information received on 27-Sep-2019 regarding an unsolicited valid non-serious case received from a Consumer/Non-HCP.  This case involves female patient who experienced fever (pyrexia), chills (chills) and sick (malaise), while she received vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. At the time of the event, the patient had ongoing Breast cancer.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site.  On an unknown date, the patient developed a non-serious fever (pyrexia), chills and sick (malaise) (Unknown latency) following the administration of INFLUENZA VACCINE.  (Other relevant tests included no lab data.) Final diagnosis was sick, chills and fever.  It was not reported if the patient received a corrective treatment.  The event outcome is reported as Unknown for fever, chills and sick.  Information on the batch number was requested.  List of documents held by sender: none.
Sex: U
Vaccine: FLU3
Symptoms: No adverse event, Overdose, Product administered to patient of inappropriate age
Clinical narrative: gave Fluzone High-Dose to patient Under 65 year age / no AE; gave Fluzone High-Dose to patient Under 65 year age / no AE; Initial information received on 27-Sep-2019 regarding an unsolicited valid non-serious case received from a non-hcp (office staff).  This case involves unknown demographic (patient under 65 year age) patient who received  INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] (lot number and Expiry date unknown) via unknown route in unknown administration site.  The patient's medical history and concomitant medications were not reported.  It was an actual medication error case due to inappropriate age at vaccine administration and overdose.   At a time of reporting no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Information on the batch number was requested.  List of documents held by sender: none.
Sex: F
Vaccine: FLU4
Symptoms: Chills, Malaise, Pyrexia
Clinical narrative: sick; chills; fever; Initial information received on 27-Sep-2019 regarding an unsolicited valid non-serious case received from a health care professional.  This case involves female patient unknown age who was sick (malaise), had chills (chills) and fever (pyrexia), while she received vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  At the time of the event, the patient had ongoing Breast cancer.  On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot number not reported via unknown route in unknown administration site.  On an unknown date, the patient developed a non-serious events sick (malaise), chills (chills) and fever (pyrexia), next day (1 day) following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  Other relevant tests were not reported.  Final diagnosis was fever, chills and sick.  It was not reported if the patient received a corrective treatment.  The outcome of the events was not reported.  Reporter felt these events were as a result of the vaccine.  Information on the batch number was requested.  List of documents held by sender: none.
Sex: M
Vaccine: FLU3
Symptoms: No adverse event, Syringe issue, Underdose
Clinical narrative: administered the Fluzone High Dose last night and it leaked around the hub of the syringe, no adverse event; administered the Fluzone High Dose last night and it leaked around the hub of the syringe, the patient did get some dose but not all, no adverse event; Initial and follow-up information received on 27-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 74 years old male patient who was administered the INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE], prefilled syringe last night and it leaked around the hub of the syringe, (lot number: UJ213A, exp date: 26-Mar-2020 in arm NOS via unknown route on 26-Sep-2019.   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant vaccination included PNEUMOCOCCAL VACCINE POLYSACCH 23V (PNEUMOVAX) for Immunisation.  It was a case of actual medication error due to vaccine underdose (underdose).  This was also a case of device issue (syringe leak).  Case details: Nurse states she administered the Fluzone High Dose last night to a male patient and the vaccine leaked around the hub of the syringe. The patient only got about ¼ to a ½ of the dose. The patient was not of good health.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.
Sex: M
Vaccine: FLU3
Symptoms: No adverse event, Overdose, Product administered to patient of inappropriate age
Clinical narrative: accidentally administered the Fluzone high dose to a 64 year patient rather than 65 year old, no adverse event; accidentally administered the Fluzone high dose to a 64 year patient rather than 65 year old, no adverse event; Initial information received on 27-Sep-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 64 years old male patient who was accidentally administered the INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE], lot UJ253AB via intramuscular route in unknown administration site, on 19-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Reporter was not sure according to the chart if the patient had any other vaccines during the same visit.   This was a case of actual medication error due to product administered to patient of inappropriate age and overdose.  Caller said that the accidentally administered the Fluzone high dose to a 64 year patient rather than 65 year old. Caller said that he will be 65 years old next month.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Documents held by sender: none.
Age: 14.0
Sex: F
Vaccine: TYP
Symptoms: Exposure via skin contact, Incorrect dose administered, Syringe issue
Clinical narrative: all the medication went down the patients arm, didn't feel anything go in her arm, no AE; Typhim syringe that started leaking, fault of the syringe, no AE; all the medication went down the patients arm, didn't feel anything go in her arm so readministered the injection, no AE; Initial information received on 27-Sep-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 14 years old female patient who had exposure via skin contact, Inappropriate dose of vaccine administered and syringe issue while she received vaccine TYPHOID VI POLYSACCHARIDE VACCINE [TYPHIM VI].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 27-Sep-2019, the patient received a Dose of suspect TYPHOID VI POLYSACCHARIDE VACCINE lot R2A26, exp date: May 10, 2021 via intramuscular route in the left deltoid.  On 27-Sep-2019, while administering the vaccine as HCP pressed on the plunger, all the medication went down the patients arm, patient didn't feel anything go in her arm so she readministered the injection (exposure via skin contact). While placing the needle on the syringe she heard a "cracking sound" but nothing leaked out at that time. HCP states that was fault of the syringe. It was stated that the carton did not have any damage upon arrival but the cartons from shipping are opened by their purchasing department and she didn't notice any leaking before the injection nor any damage to the carton the actual syringe was in.  It was case of actual medication error due to Inappropriate dose of vaccine administered.  At the time of the report, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error  List of documents held by the sender: none
Age: 67.0
Sex: M
Vaccine: FLU3, FLUR4
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Fluzone High- Dose to be administered to a 67 year old man, MA administered Flublok Quadrivalent instead, no AE; Initial information received on 27-Sep-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 67 years old male patient who received 0.5 ml dose of vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] (lot QFAA1905, Exp. Date 21-May-2021 via unknown route in unknown administration site) instead of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE], on 27-Sep-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was an actual medication error case due to wrong vaccine administered.  It was reported that MD order was for Fluzone High- Dose to be administered to a 67 year old man. The MA administered Flublok Quadrivalent instead.  No adverse effects reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.
Sex: F
Vaccine: DTAPIPV, TDAP
Symptoms: No adverse event, Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: a 9 year old female patient received a dose of Quadracel/No AE; a 9 year old female patient received a dose of Quadracel instead of Adacelwhich was prescribed/No AE; a 9 year old female patient was prescribed a dose of Adacel/No AE; Initial information received on 27-Sep-2019 regarding an unsolicited valid non-serious case received from an other health care professional.  This case is linked to case 2019SA272368.  This case involves a nine years old female patient received a 0.5 ml booster dose of DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE [QUADRACEL] lot C5635AA, expiry date: 18-Jun-2021 via intramuscular route in the left deltoid on 23-Sep-2019 instead of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] which was prescribed to her.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 23-Sep-2019, the patient received a dose Booster dose of suspect DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE lot C5635AA via intramuscular route in the left deltoid.  It was an actual medication error due to inappropriate age at vaccine administration, wrong vaccine administered and product prescribing error.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.
Age: 11.0
Sex: F
Vaccine: DTAPIPVHIB, TDAP
Symptoms: No adverse event, Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: 11 year old consumer to receive Pentacel and not the Adacel that was prescribed, no AE; 11 year old consumer to receive Pentacel and not the Adacel that was prescribed, no AE; Initial information received on 27-Sep-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case is linked to case 2019SA272344 (same reporter).  This case involves a 11 years old female patient who received 0.5 ml dose (booster dose) of vaccine DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] (lot UJ019AAA, expiry date: 09-Oct-2020) via intramuscular route in left deltoid instead of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] that was prescribed on 23-Aug-2019.  It was a case of actual medication error due to wrong vaccine administered and inappropriate age at vaccine administration.  It was reported that 11 year female patient old consumer to receive Pentacel and not the Adacel that was prescribed.  At the time of reporting, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.
Age: 32.0
Sex: F
Vaccine: PPV
Symptoms: Lip swelling, Peripheral swelling, Rash, Swelling
Clinical narrative: My lips have swollen about 6 different times (1 time per side upper left, upper right side, lower right side,lower left side) all at different. Also my finger, toe, and side have all swollen at different times. I have also had rashes on my legs, hands, arms, stomach.
Age: 7.0
Sex: M
Vaccine: FLU4
Symptoms: Erythema, Peripheral swelling, Skin warm
Clinical narrative: Parent states child's left arm became reddened and swollen one hour after injection was given. Parent states redness and swelling have spread across the child's arm and is now warm to touch and hard. Parent states she gave the child benadryl and ibuprofen to the child. Parent states she applied an ice pack to the left arm.
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, Axillary pain, Cyst, Groin pain, Headache
Clinical narrative: Spotting  started 4 days after vaccine and lasted for 2 days.  Localized pain on areas of the head/forehead, left elbow, left armpit, groin crease area on both sides started 3 days after the vaccine Inflammed cyst formed under right armpit 4 days after the vaccine and one week later the swelling has decreased, but it is still there.
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Inflammation, Pain, Swelling, Vaginal haemorrhage
Clinical narrative: Spotting  started 4 days after vaccine and lasted for 2 days.  Localized pain on areas of the head/forehead, left elbow, left armpit, groin crease area on both sides started 3 days after the vaccine Inflammed cyst formed under right armpit 4 days after the vaccine and one week later the swelling has decreased, but it is still there.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Erythema, Induration, Pyrexia
Clinical narrative: Redness-- > Monday doubled in size, fever, no heat,  hardness, chills on Monday and Tuesday; Tuesday doubled again, MD Tuesday afternoon started Keflex h/x of MRSA
Age: 6.0
Sex: M
Vaccine: FLU4
Symptoms: Cellulitis, Injection site erythema, Injection site swelling
Clinical narrative: swelling, spreading redness extending from injection site with treatment of Benadryl x 2 - dx of cellulitis, tx with higher dose of Benadryl and steroid Rx
Age: 54.0
Sex: F
Vaccine: FLU4
Symptoms: Bone pain, Joint range of motion decreased, Pain
Clinical narrative: Patient is an employee who is a nurse who works in ED. Reported to me today that she had severe pain all over her body, deep "crushing" bone pain and limited range of motion in arms. No treatment. Resolved in 24 hours.
Age: 80.0
Sex: F
Vaccine: FLU3
Symptoms: Heart rate irregular, Malaise
Clinical narrative: Patient reports she was not feeling well the next day (10/02/2019) and was experiencing "irregular heart beat".  Went to ER on 10/03/2019. Reported symptoms 10/04/2019. Patient states she feels "fine" today.
Age: 76.0
Sex: M
Vaccine: PPV
Symptoms: Injection site bruising, Injection site swelling
Clinical narrative: Patient presented 12 days after injection with a large bruise at the injection site.   Patient stated the site was swollen initially then turn bruised and has been healing since.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMRV
Symptoms: Injection site inflammation, Vaccination complication
Clinical narrative: Two days ago DTAP+ IPV IM given in left thigh, MMR+ Varicella subcutaneously given in right thigh. Findings today consistent with localized, inflammation delayed reaction to vaccines. Sites marked. Cool compresses and motrin encouraged. Sites' symptoms should not worsen. Monitor for increasing redness, pain, drainage, and swelling- if these occur he needs to be reevaluated, office open weekends and evenings.  Should not be scratching as it can make worse.
Age: 10.0
Sex: F
Vaccine: FLU4
Symptoms: Chest discomfort, Flushing, Malaise
Clinical narrative: Within 1-2 minutes of receiving vaccine pt developed facial flushing  and reported she didn't fell well. Also reports feeling pressure in her chest. Pt was laid down and within 3-5 minutes her symptoms had resolved. By the time I examined her (about 5 minutes after she developed the reaction), she had a normal exam and felt fine. I believe we gave her something to drink.
Age: 62.0
Sex: M
Vaccine: FLU4
Symptoms: Peripheral swelling
Clinical narrative: patient friend called, said there was an adverse effect to flu shot that the pt received, they called their insurance nurse, nurse told them to call pharmacy to report adverse event, said that pt arm was swollen from shoulder to middle arm, was told to put ice and take acetaminophen
Age: 76.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Chills, Headache
Clinical narrative: Headache which progressed to a more severe headache.  Severe chills.
Age: 68.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Arthralgia, Chills, Injection site pain, Pain
Clinical narrative: Patient experienced pain at injection site, overall joint/body aches,  fatigue, and severe chills that started the evening after vaccination.  Will apply ice to arm, rest and take otc pain medication of choice (tylenol/ibuprofen) if needed to help with pain and discomfort.  Will follow up with pharmacy or physician if symptoms worsen or do not resolve in 2 days.
Age: 74.0
Sex: F
Vaccine: FLUA3, VARZOS
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: Patient called pharmacist 2 days after receiving the Fluad and Shingrix vaccines to report that she developed a red, raised, and slightly warm red patch on her upper arm approximately 24 hours after being vaccinated.  This was the same arm in which she received the vaccines.  The spot was not painful and did not particularly bother her aside from the intermittent itching. Patient said she was not experiencing any signs on anaphylaxis and would continue to monitor. She believes it had improved since the day before.
Age: 70.0
Sex: M
Vaccine: VARZOS
Symptoms: Petechiae, Pruritus, Rash
Clinical narrative: Severe skin rash that the patient described as petechiae that stretched from his knees to his torso and back. Had a severe itch. Had to go to the doctor and got a prescription for triamcinolone.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Blood glucose increased, Dehydration, Type 1 diabetes mellitus
Clinical narrative: Diabetes Mellitus Type 1, became very dehydrated, blood sugars were in the 900's, taken to the hospital and was given insulin and fluids and continue to take insulin daily, for the rest of my life to survive.
Age: 65.0
Sex: F
Vaccine: FLUR4
Symptoms: Erythema, Haemorrhage subcutaneous, Peripheral swelling, Skin warm
Clinical narrative: patient arm swollen, red and hot. two hours later she returns with some signs of bleeding under the skin on the same arm.  First advised the patient to take some Benadryl, the when she returns I advise to check with urgent care
Age: 66.0
Sex: F
Vaccine: FLU3, VARZOS
Symptoms: Dry skin, Erythema, Pain, Skin exfoliation, Skin warm
Clinical narrative: No side effects from Flu Shot.  Side effects of Shringrix  Shot #1: - Next day - soreness, redness, slight pain - Next day - very sore, redness traveling down arm (from top of arm) to elbow - Pain - had to take Tylenol. - Arm was extremely HOT and BLOOD  RED for 4 days  - Used cold packs on arm. - After 4 days, redness started going away - October 1 - noticed a "peeling" (dry, flakey skin) at top of arm near injection site. - Skin issue still there.  I put lotion on to give it moisture.
Age: 78.0
Sex: M
Vaccine: FLUA3, PPV
Symptoms: Insomnia, Pain in extremity
Clinical narrative: Patient called pharmacist approximately 24 hours after receiving the Fluad and Pneumovax23 vaccines. He reported that the left arm, the arm in which the Pneumovax23 was administered, was causing him a great deal of pain the night before. He said it was difficult to sleep that night. During the conversation with the pharmacist he reported that his pain had since significantly improved and that he was not experiencing any other complications such as redness, swelling, allergic reaction, or loss of arm function/mobility. He did not feel like he needed to follow up with his primary doctor as his arm pain was much improved.
Age: 32.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: pain 3/10 right deltoid affected site 98.6, 84, 20, 97 % on room air, 117/79, 5 ft., 134.2 lbs. Right deltoid area  with erythematous  patch  appears oval size shape approximately  1.5-inch x 3/4 inch in diameter, afebrile, no ulceration
Age: 24.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site warmth
Clinical narrative: Pt reports an itchy, warm, painful, red spot at the sign of the injection that began the evening of receiving Afluria. Pt came in to pharmacy 3 days and 4 days afterwards to be seen by two different pharmacists. Both pharmacists, including myself, determined the reaction to be allergic in nature and advised pt to take Benadryl at night. On second visit to pharmacy, pt reported reaction to be the same or a little bit better and not getting any worse.
Age: 69.0
Sex: F
Vaccine: FLU3, VARZOS
Symptoms: Body temperature increased, Chills, Neck pain, Pain
Clinical narrative: patient reports pain radiation across upper body and up neck, temperature of 101.0, and shivers.   She took a Percocet  that night for the pain and symptoms resolved within a day.
Sex: F
Vaccine: FLU4
Symptoms: Abdominal discomfort, Chills, Dizziness, Headache, Myalgia
Clinical narrative: Patient woke up at 2am, symptoms included: muscle aches, headache, upset stomach, profuse vomiting, chills, body aches and dizziness.  Has not taken any medicine or called the vaccine administrator.    Symptoms similar as the last time received vaccines. Currently, dizziness is gone but headache still is there.
Sex: F
Vaccine: FLU4
Symptoms: Pain, Vomiting
Clinical narrative: Patient woke up at 2am, symptoms included: muscle aches, headache, upset stomach, profuse vomiting, chills, body aches and dizziness.  Has not taken any medicine or called the vaccine administrator.    Symptoms similar as the last time received vaccines. Currently, dizziness is gone but headache still is there.
Age: 3.0
Sex: M
Vaccine: FLU3
Symptoms: Cellulitis, Injection site cellulitis
Clinical narrative: Patient had a secondary cellulitis around the injection site and into his right arm and neck.
Age: 43.0
Sex: F
Vaccine: HPV9
Symptoms: Injection site erythema, Injection site mass, Injection site swelling, Injection site warmth, Limb discomfort
Clinical narrative: Arm was sore for three days. Patient denies any swelling or redness. On the third day in the morning patient noted redness and swelling at the injection site. Denies fever, but states injection site was hot to touch. Patient called clinic and was advised to go to the walk in clinic. Patient was seen at the walk in clinic on 9/26/19. Antibiotics and Motrin were prescribed. Dx of cellulitis was made. patient states she completed antibiotic therapy. Patient states it took 3-4 days following start of  antibiotics for the swelling and redness to go down. Currently patient feels a lump under the skin at the injection site. Patient states it felt like her arm was asleep starting on the third day after injection. Patient states are still feels weak.
Age: 68.0
Sex: M
Vaccine: UNK
Symptoms: Asthenia, Body temperature increased, Chills, Clumsiness, Dyskinesia
Clinical narrative: 3.5 hours after getting the shot, I had massive chills and accompanying shaking -- hand and arm movements of 6-12 inches. I had difficulty walking, being very clumsy, bumping into things, and having to use fixed objects (doorways...) to help guide myself. Was weak -- took multiple tries to get up from a recliner. There was also stiffness in the muscles. The injection site was only slightly tender. Temperature for 8pm-12M varied slightly around 103.6 degrees. When I went to bed at 3am it was down to 102.2 degrees. At 7am it was 101.8; at 1pm 99.6. At 24 hours after the shot, still stillness. I have had annual flu shots for as long as I can remember, and never had anything more than a mild reaction.  Reporting this because the rapid onset of symptoms and the severity could put people in danger if they are out-and-about.
Age: 68.0
Sex: M
Vaccine: UNK
Symptoms: Gait disturbance, Injection site pain, Musculoskeletal stiffness, Tremor
Clinical narrative: 3.5 hours after getting the shot, I had massive chills and accompanying shaking -- hand and arm movements of 6-12 inches. I had difficulty walking, being very clumsy, bumping into things, and having to use fixed objects (doorways...) to help guide myself. Was weak -- took multiple tries to get up from a recliner. There was also stiffness in the muscles. The injection site was only slightly tender. Temperature for 8pm-12M varied slightly around 103.6 degrees. When I went to bed at 3am it was down to 102.2 degrees. At 7am it was 101.8; at 1pm 99.6. At 24 hours after the shot, still stillness. I have had annual flu shots for as long as I can remember, and never had anything more than a mild reaction.  Reporting this because the rapid onset of symptoms and the severity could put people in danger if they are out-and-about.
Age: 51.0
Sex: M
Vaccine: FLUC4
Symptoms: Immediate post-injection reaction, Myalgia, Pain, Tenderness
Clinical narrative: sharp pain immediately after vaccine, pain has persisted for now the two weeks post and continues. sharp pain, sore muscular pain, hurst to lift arm, tender
Age: 66.0
Sex: M
Vaccine: PPV
Symptoms: Erythema, Peripheral swelling, Skin warm
Clinical narrative: Pt had prevnar 13 on 10/2/18.  Pneumovax 23 was last vaccine to give.  Patient stated the next morning he felt like his arm was swollen, warm to touch below injection site.  The pharmacist yesterday instructed him to ice and use an anti-inflammatory.  Patient came in today around 3:16pm stating his arm was still swollen and red, but the redness had moved down his arm.  The swelling was above and below elbow.  Contacted the patient's pcp Dr. and left a message.  Instructed the patient to go to the urgent care next door, but he said he would ice it and take Naproxen.  We had him mark his arm, and I instructed him if the redness expands or is still warm to touch seek medical treatment.
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site rash
Clinical narrative: Patient noticed rash at injection site of shingrix morning of 10/4/19. Told patient she could take benadryl to help speed up the healing process or it would resolve on its on. Rash was about one inch by one inch.
Age: 67.0
Sex: M
Vaccine: VARZOS
Symptoms: Chills, Fatigue, Head discomfort, Injection site pain
Clinical narrative: Shivers, fatigue, stuffy head, pain in injection site
Age: 81.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Injection site discolouration, Injection site pruritus, Injection site warmth, Swelling
Clinical narrative: patient came in on 10/4/19-reported red swollen area of arm around half circumference of arm.  are was about size of her hand. injection site had black and blue small area.  patient said was warm to touch, and occasionally it was itchy.  she came in because her dermatologist examined her.  she said she didn't think it got worse symptoms since injection. she will monitor , use cold compresses, and see doctor possibly / if gets worse.
Age: 69.0
Sex: F
Vaccine: DTAP, VARZOS
Symptoms: Dizziness, Lethargy
Clinical narrative: Total and complete lethargy.  And it hasn't gotten much better since. I couldn't function for the first 2 weeks after.  About the 2nd or third day, I woke up with stopped-up ears and dizziness, that didn't go away so I went to Urgent care. That doctor said my ears look clear but said I had Vertigo and gave me a prescription for Prednisone and one for Meclizine. I finished the Prednisone but only feel about 11% better.  I already had an appointment with my Family doctor on 10/03/2019, for a medication and he's sending me to an ENTon Oct 22, 2019.   I don't know what's going on but  I'm miserable. I'm also not sure if was the vaccines. But it all started AFTER I had them.
Age: 57.0
Sex: F
Vaccine: VARZOS
Symptoms: Burning sensation, Migraine, Pyrexia, Rash
Clinical narrative: 12 hours after the vaccination the patient developed a fever she measured at 102 F. The fever lasted over 24 hours with little respite after taking OTC ibuprofen and acetaminophen. While she had the fever she also had a severe migraine headache. After the headache and the migraine abated the patient developed a rash on her neck that is burning.
Age: 45.0
Sex: F
Vaccine: TD
Symptoms: Fine motor skill dysfunction, Muscular weakness, Pain
Clinical narrative: 3 days of severe pain and global weakness of entire right upper extremity; loss of dexterity of right hand; progressive, unremitting pain; symptoms continuing
Age: 69.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Injection site erythema, Injection site nodule, Injection site pain, Injection site swelling, Pyrexia
Clinical narrative: red, swollen, painful knot at injection site with fever
Age: 7.0
Sex: M
Vaccine: UNK
Symptoms: Blood urine absent, Body temperature increased, Glucose urine absent, Malaise, Nitrite urine absent
Clinical narrative: Patient reports that he began to feel ill immediately following his vaccination. He had a temperature recorded by his mother at 5pm and his temperature was 102.9. He was brought into the walk-in clinic for possible adverse reaction. A rapid strep test was positive in the clinic and the patient was treated for strep. It is possible that the vaccination coincided with bacterial infection. I feel his reaction was due to illness from strep bacteria and not caused from vaccine.  Mother comforted that the VAERS was filed.
Age: 7.0
Sex: M
Vaccine: UNK
Symptoms: Protein urine present, Specific gravity urine normal, Streptococcal infection, Streptococcus test positive, Urine bilirubin decreased
Clinical narrative: Patient reports that he began to feel ill immediately following his vaccination. He had a temperature recorded by his mother at 5pm and his temperature was 102.9. He was brought into the walk-in clinic for possible adverse reaction. A rapid strep test was positive in the clinic and the patient was treated for strep. It is possible that the vaccination coincided with bacterial infection. I feel his reaction was due to illness from strep bacteria and not caused from vaccine.  Mother comforted that the VAERS was filed.
Age: 7.0
Sex: M
Vaccine: UNK
Symptoms: Urine ketone body absent, Urobilinogen urine decreased, White blood cells urine negative, pH urine normal
Clinical narrative: Patient reports that he began to feel ill immediately following his vaccination. He had a temperature recorded by his mother at 5pm and his temperature was 102.9. He was brought into the walk-in clinic for possible adverse reaction. A rapid strep test was positive in the clinic and the patient was treated for strep. It is possible that the vaccination coincided with bacterial infection. I feel his reaction was due to illness from strep bacteria and not caused from vaccine.  Mother comforted that the VAERS was filed.
Age: 27.0
Sex: M
Vaccine: FLU4
Symptoms: Blood pressure increased, Dizziness, Feeling abnormal, Headache, Hypoaesthesia
Clinical narrative: His fiancee call the pharmacy about 2 hours after he got his flu shot. He was feeling dizzy, had numbness in his face, and his blood pressure was elevated. He did not have any breathing problems. He had been working outside in the hot sun. The RPh told him to come inside and sit down and cool off for a while to see if he improved. He showed up at the pharmacy about 3 hours later, and he still felt poorly but blood pressure had improved. RPh advised him to take Benadryl. He said is could not.  She then suggested Claritin or Zyrtec and to see medical attention if his symptoms did not improve. I called him today. He said all of his symptoms have went away and he is feeling better except for a bad headache today.
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Blister, Burning sensation, Headache, Influenza like illness, Injection site erythema
Clinical narrative: blistering pain, flu like symptoms, headache, huge reddish rash around shot area (left arm) blurred vision, burning sensations for over a week duration
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site rash, Pain, Vision blurred
Clinical narrative: blistering pain, flu like symptoms, headache, huge reddish rash around shot area (left arm) blurred vision, burning sensations for over a week duration
Age: 66.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Peripheral swelling, Vaccination complication
Clinical narrative: Patient reported swelling in left arm for 1 day following the vaccination. She was advised to see the doctor to make sure it was not an infection. The doctor treated her with benadryl and told her it was likely a reaction to her shots. She followed up with us after her doctor's appointment and she said the swelling has significantly decreased.